Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19
Fang Liu, Li Lin, Mengda Xu, Juan Wu, Ding Luo, YuSi Zhu, Bixi Li, Xiaoyang Song, Xiang Zhou
Journal of Clinical Virology, Vol. 127, pp. 104370–104370 (2020)
10.1016/j.jcv.2020.104370
PMID: 32344321
Abstract
Topics
Field: Medicine · Subfield: Infectious Diseases
Keywords
Procalcitonin,Medicine,Internal medicine,C-reactive protein,Coronavirus disease 2019 (COVID-19),Gastroenterology,Hazard ratio,Proportional hazards model,Retrospective cohort study,Severity of illness
MeSH Terms
UN Sustainable Development Goals
- Good health and well-being (0.81)
All Available Versions
- Landing page — Journal of Clinical Virology publishedVersion
- Landing page — PubMed publishedVersion
- Landing page — PubMed Central submittedVersion
Citations by Year
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| 15 | 39 | 106 | 202 | 292 | 332 | 209 |
- Prognostic value of interleukin-6, C-reactive protein, and procalcitonin in patients with COVID-19 2020 · 1196
- The epidemiology of human papillomavirus infections 2005 · 975
- Antiviral drugs in current clinical use 2004 · 951
- Coagulation disorders in coronavirus infected patients: COVID-19, SARS-CoV-1, MERS-CoV and lessons from the past 2020 · 932
- The papillomavirus life cycle 2005 · 858
Continue on JournalsHub
Put what you just read into practice with these free tools.